Encompass Health Corp
Research Encompass Health Corp (EHC) on Bullrun: valuation model: 3.0% overvalued, market cap USD 11.92B, P/E 19.6, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEHC
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyUSD
- Valuation signal3.0% overvalued
- Market capUSD 11.92B
- P/E19.6
- Dividend yield0.6%
- Financial periodQ2 2026
- RevenueUSD 1.60B
- Net incomeUSD 153.90M
- Free cash flowUSD 62.30M
- Gross margin95.9%
Valuation Snapshot
Bullrun's latest valuation model marks Encompass Health Corp as 3.0% overvalued; latest market cap is USD 11.92B; P/E is 19.6; dividend yield is 0.6%.
Peer valuation comparison
Latest P/E is 19.56x versus a Healthcare sector median of 24.46x (20.0% below).
Latest dividend yield is 0.64% versus a Healthcare sector median of 2.11% (69.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 5.94B | USD 566.20M | USD 439.20M | 69.9% | 5.54 | USD 72.20M | USD 2.71B | USD 2.44B |
| FY2024 | USD 5.37B | USD 455.70M | USD 360.30M | 41.6% | 4.46 | USD 85.40M | USD 2.71B | USD 2.07B |
| FY2023 | USD 4.80B | USD 352.00M | USD 267.70M | n/a | 3.47 | USD 69.10M | USD 2.93B | USD 1.65B |
| FY2022 | USD 4.35B | USD 271.00M | USD 141.00M | n/a | 2.7 | USD 21.80M | USD 3.53B | USD 1.31B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 11.92B | 19.6 | 0.6% | 0.76 |
| 2025 | 2025-12-31 | USD 10.61B | 19.2 | 0.7% | 0.7 |
| 2024 | 2024-12-31 | USD 9.31B | 20.7 | 0.5% | 0.47 |
| 2023 | 2023-12-29 | USD 6.69B | 19.1 | 1.1% | 0.75 |
| 2022 | 2022-12-30 | USD 5.97B | 22.0 | 1.7% | 1.02 |
| 2021 | 2021-12-31 | USD 5.17B | 12.6 | 1.7% | 0.88 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.76 USD, yield 0.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.72 USD |
| FY2024 | 0.64 USD |
| FY2023 | 0.6 USD |
| FY2022 | 0.86 USD |
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Encompass Health Corp overvalued or undervalued?
Bullrun's valuation model currently marks Encompass Health Corp as 3.0% overvalued.
What is Encompass Health Corp's market cap?
Encompass Health Corp's market capitalization is USD 11.92B.
What is Encompass Health Corp's P/E ratio?
Encompass Health Corp's price-to-earnings (P/E) ratio is 19.6.
Does Encompass Health Corp pay a dividend?
Encompass Health Corp has a dividend yield of 0.6%.
What does Encompass Health Corp do?
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex.